Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

NCT07741656 is registered in ClinicalTrials.gov with Andromeda Surgical as lead sponsor.

NCT NCT07741656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)
Lead sponsor
Andromeda Surgical
Phase
Not applicable
Overall status
Recruiting
Start date
September 26, 2025
Completion date
January 31, 2027
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia), holep (holmium laser enucleation of prostate)